Paying users zone. Data is hidden behind: .
Get 1-month access to Danaher Corp. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Danaher Corp. pages available today for free:
Analysis of Profitability Ratios
Quarterly Data
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Danaher Corp., profitability ratios (quarterly data)
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Danaher Corp.’s gross profit margin ratio deteriorated from Q2 2020 to Q3 2020 but then improved from Q3 2020 to Q4 2020 exceeding Q2 2020 level. |
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Danaher Corp.’s operating profit margin ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Danaher Corp.’s net profit margin ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Danaher Corp.’s ROE improved from Q2 2020 to Q3 2020 but then deteriorated significantly from Q3 2020 to Q4 2020. |
ROA | A profitability ratio calculated as net income divided by total assets. | Danaher Corp.’s ROA improved from Q2 2020 to Q3 2020 but then deteriorated significantly from Q3 2020 to Q4 2020. |
Gross Profit Margin
Danaher Corp., gross profit margin calculation (quarterly data)
Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Gross profit | ||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||
Profitability Ratio | ||||||||||||||||||||||||||
Gross profit margin1 | ||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||
Gross Profit Margin, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | ||||||||||||||||||||||||||
Boston Scientific Corp. | ||||||||||||||||||||||||||
Edwards Lifesciences Corp. | ||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||
Stryker Corp. | ||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | ||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
1 Q4 2020 Calculation
Gross profit margin = 100
× (Gross profitQ4 2020
+ Gross profitQ3 2020
+ Gross profitQ2 2020
+ Gross profitQ1 2020)
÷ (SalesQ4 2020
+ SalesQ3 2020
+ SalesQ2 2020
+ SalesQ1 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Danaher Corp.’s gross profit margin ratio deteriorated from Q2 2020 to Q3 2020 but then improved from Q3 2020 to Q4 2020 exceeding Q2 2020 level. |
Operating Profit Margin
Danaher Corp., operating profit margin calculation (quarterly data)
Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Operating profit | ||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||
Profitability Ratio | ||||||||||||||||||||||||||
Operating profit margin1 | ||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||
Operating Profit Margin, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | ||||||||||||||||||||||||||
Boston Scientific Corp. | ||||||||||||||||||||||||||
Edwards Lifesciences Corp. | ||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||
Stryker Corp. | ||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | ||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
1 Q4 2020 Calculation
Operating profit margin = 100
× (Operating profitQ4 2020
+ Operating profitQ3 2020
+ Operating profitQ2 2020
+ Operating profitQ1 2020)
÷ (SalesQ4 2020
+ SalesQ3 2020
+ SalesQ2 2020
+ SalesQ1 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Danaher Corp.’s operating profit margin ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Net Profit Margin
Danaher Corp., net profit margin calculation (quarterly data)
Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Net earnings | ||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||
Profitability Ratio | ||||||||||||||||||||||||||
Net profit margin1 | ||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||
Net Profit Margin, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | ||||||||||||||||||||||||||
Boston Scientific Corp. | ||||||||||||||||||||||||||
Edwards Lifesciences Corp. | ||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||
Stryker Corp. | ||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | ||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
1 Q4 2020 Calculation
Net profit margin = 100
× (Net earningsQ4 2020
+ Net earningsQ3 2020
+ Net earningsQ2 2020
+ Net earningsQ1 2020)
÷ (SalesQ4 2020
+ SalesQ3 2020
+ SalesQ2 2020
+ SalesQ1 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Danaher Corp.’s net profit margin ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Return on Equity (ROE)
Danaher Corp., ROE calculation (quarterly data)
Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Net earnings | ||||||||||||||||||||||||||
Total Danaher stockholders’ equity | ||||||||||||||||||||||||||
Profitability Ratio | ||||||||||||||||||||||||||
ROE1 | ||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||
ROE, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | ||||||||||||||||||||||||||
Boston Scientific Corp. | ||||||||||||||||||||||||||
Edwards Lifesciences Corp. | ||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||
Stryker Corp. | ||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | ||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
1 Q4 2020 Calculation
ROE = 100
× (Net earningsQ4 2020
+ Net earningsQ3 2020
+ Net earningsQ2 2020
+ Net earningsQ1 2020)
÷ Total Danaher stockholders’ equity
= 100 × ( + + + )
÷ =
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Danaher Corp.’s ROE improved from Q2 2020 to Q3 2020 but then deteriorated significantly from Q3 2020 to Q4 2020. |
Return on Assets (ROA)
Danaher Corp., ROA calculation (quarterly data)
Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Net earnings | ||||||||||||||||||||||||||
Total assets | ||||||||||||||||||||||||||
Profitability Ratio | ||||||||||||||||||||||||||
ROA1 | ||||||||||||||||||||||||||
Benchmarks | ||||||||||||||||||||||||||
ROA, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | ||||||||||||||||||||||||||
Boston Scientific Corp. | ||||||||||||||||||||||||||
Edwards Lifesciences Corp. | ||||||||||||||||||||||||||
Intuitive Surgical Inc. | ||||||||||||||||||||||||||
Medtronic PLC | ||||||||||||||||||||||||||
Stryker Corp. | ||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | ||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-22), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21).
1 Q4 2020 Calculation
ROA = 100
× (Net earningsQ4 2020
+ Net earningsQ3 2020
+ Net earningsQ2 2020
+ Net earningsQ1 2020)
÷ Total assets
= 100 × ( + + + )
÷ =
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROA | A profitability ratio calculated as net income divided by total assets. | Danaher Corp.’s ROA improved from Q2 2020 to Q3 2020 but then deteriorated significantly from Q3 2020 to Q4 2020. |